Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamilton Robotics Builds Affymetrix’ CytoScan Automated Target Preparation Solution on Microlab NIMBUS

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
Customized Microlab NIMBUS 96 workstation helps speed clinical research with Affymetrix’ CytoScan Cytogenetics Solution.

Hamilton Robotics has announced that the soon-to-launch CytoScan Automated Target Preparation Solution from Affymetrix, Inc. is built on the customizable Microlab® NIMBUS 96 workstation from Hamilton Robotics. The Affymetrix NIMBUS Target Preparation Instrument automates target preparation for the CytoScan Cytogenetics Solution, which offers the broadest coverage and highest performance for detecting human chromosomal aberrations.

"Affymetrix chose to custom-design the NIMBUS workstation to automate sample preparation for its CytoScan Assay because the NIMBUS is a superior product at an affordable price compared to other liquid handling robots on the market. The exciting new system increases sample throughput at least two-fold for laboratories offering the CytoScan Solution for cytogenetic research applications while maintaining the same high performance," says Tanya Petrossian, Ph.D. Global Strategic Product Manager at Affymetrix.

"As an OEM partner, Hamilton Robotics was outstanding," continued Petrossian. "They worked side by side with us onsite during the early product development stage to ensure that the workstation was optimized to fit the requirements of the CytoScan Cytogenetics Solution workflow."

The Microlab NIMBUS96 is a customizable instrument platform that offers speed, ease of use, and superior pipetting performance in a small footprint for budget-conscious laboratories. The flexible system combines incredibly accurate liquid measurement with software that provides unprecedented workflow control, file handling, and integration with third-party devices. The compact, affordable system allows laboratories to process up to 96 samples at a time.
 
"Hamilton Robotics is thrilled to partner with Affymetrix to address the challenging requirements of cytogenetic researchers. Our workstations are easily adapted to even the most complex sample preparation needs of both the research environment and the rigid demands of regulated environments,” says Scott Eaton, Director of OEM and International Sales at Hamilton Robotics.

Hamilton Robotics tailor-made the Affymetrix NIMBUS for the CytoScan Assay using its rigorous custom-build process, which includes system definition, final design and system assembly, factory acceptance testing, and site acceptance testing.

“A custom-built Hamilton NIMBUS workstation offers superior quality for the same or lower price as other products on the market," says Jose Carle, Vice President at Hamilton Robotics. "Our experienced design teams, including application specialists, work closely with customers to ensure the final product perfectly matches the particular needs of the process."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hamilton Robotics and French Police Scientifique Publish Paper Describing Large-Scale Production of Genetic Profiles
More than 300,000 profiles have already been processed on the Hamilton platforms and stored in French Database.
Wednesday, March 10, 2010
Automation of Adherent Cell Culture Maintenance
Hamilton, Life & Brain and University of Bonn will jointly develop a system for the automated culture of primary cells, cell lines and embryonic stem cells.
Monday, May 14, 2007
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!